For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Covid-19 update: 1719 new cases, seven deaths
FREE READ
+News
FREE READ
Covid-19 update: 1719 new cases, seven deaths
Tuesday 3 December 2024, 03:52 PM

[Image: Fusion Medical Animation on Unsplash]
There have been 1719 new cases of Covid-19 reported in New Zealand over the week to Sunday, and seven further deaths attributed to the virus.
There were 107 cases in hospital; it is not known how many of those were in intensive care.
The seven-day rolling average of new cases was 246 per day.
It comes as the first phase of the inquiry into the Covid-19 response delivered 39 recommendations and called for public health capacity to be built up to keep options open for decision-makers in future pandemics.
Last week Te Whatu Ora reported 1675 cases and six further deaths.
For more news from around New Zealand, go to RNZ.